These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11338478)

  • 1. Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus.
    Bektas N; Donner A; Wirtz C; Heep H; Gabbert HE; Sarbia M
    Am J Clin Pathol; 2000 Dec; 114(6):890-5. PubMed ID: 11338478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions.
    Geddert H; Zeriouh M; Wolter M; Heise JW; Gabbert HE; Sarbia M
    Am J Clin Pathol; 2002 Jul; 118(1):60-6. PubMed ID: 12109857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the RB protein, allelic imbalance of the RB gene and amplification of the CDK4 gene in metaplasias, dysplasias and carcinomas in Barrett's oesophagus.
    Sarbia M; Tekin U; Zeriouh M; Donner A; Gabbert HE
    Anticancer Res; 2001; 21(1A):387-92. PubMed ID: 11299766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclin E in dysplasia, carcinoma, and nonmalignant lesions of Barrett esophagus.
    Sarbia M; Bektas N; Müller W; Heep H; Borchard F; Gabbert HE
    Cancer; 1999 Dec; 86(12):2597-601. PubMed ID: 10594854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.
    Zhuang Z; Vortmeyer AO; Mark EJ; Odze R; Emmert-Buck MR; Merino MJ; Moon H; Liotta LA; Duray PH
    Cancer Res; 1996 May; 56(9):1961-4. PubMed ID: 8616831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoallelic methylation of the APC promoter is altered in normal gastric mucosa associated with neoplastic lesions.
    Clément G; Bosman FT; Fontolliet C; Benhattar J
    Cancer Res; 2004 Oct; 64(19):6867-73. PubMed ID: 15466175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.
    Villanacci V; Bellone G; Battaglia E; Rossi E; Carbone A; Prati A; Verna C; Niola P; Morelli A; Grassini M; Bassotti G
    Hum Pathol; 2008 Mar; 39(3):403-9. PubMed ID: 18261624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus.
    Bian YS; Osterheld MC; Bosman FT; Fontolliet C; Benhattar J
    Am J Clin Pathol; 2000 Oct; 114(4):583-90. PubMed ID: 11026105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus.
    Sarbia M; Arjumand J; Wolter M; Reifenberger G; Heep H; Gabbert HE
    Am J Clin Pathol; 2001 Jun; 115(6):835-40. PubMed ID: 11392879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and molecular analysis of high-grade dysplasia and early adenocarcinoma in short- versus long-segment Barrett esophagus.
    Nobukawa B; Abraham SC; Gill J; Heitmiller RF; Wu TT
    Hum Pathol; 2001 Apr; 32(4):447-54. PubMed ID: 11331963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncogene amplification and genetic heterogeneity in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus].
    Walch A; Bink K; Hutzler P; Zitzelsberger H; Braselmann H; Aubele M; Höfler H; Werner M
    Verh Dtsch Ges Pathol; 2001; 85():257-63. PubMed ID: 11894407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus.
    Hermann B; Li Y; Ray MB; Wo JM; Martin RC
    Arch Surg; 2005 Dec; 140(12):1204-9; discussion 1209. PubMed ID: 16365243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The possible role of loss of heterozygosity at APC, MCC and DCC genetic loci in esophageal carcinoma].
    Wang M; Lu R; Fang D
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):16-8. PubMed ID: 11776787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.